Literature DB >> 35670964

Papillary Thyroid Carcinoma: Current Position in Epidemiology, Genomics, and Classification.

Alfred K Lam1,2,3.   

Abstract

Papillary thyroid carcinoma is the most common type of thyroid malignancy both in adults and pediatric population. Since the 1980s, there are changes in criteria in labelling thyroid lesions as "papillary thyroid carcinomas." Radiation exposure is a well-established risk factor for papillary thyroid carcinoma. Other environmental risk factors include dietary iodine, obesity, hormones, and environmental pollutants. Papillary thyroid carcinomas could occur in familial settings, and 5% of these familial cases have well-studied driver germline mutations. In sporadic papillary thyroid carcinoma, BRAF mutation is common and is associated with clinicopathologic and prognostic markers. The mutation could aid in the clinical diagnosis of papillary thyroid carcinoma. Globally, thyroid cancer is among the top ten commonest cancer in females. In both adult and pediatric populations, there are variations of prevalence of thyroid cancer and rising incidence rates of thyroid cancer worldwide. The increase of thyroid cancer incidence was almost entirely due to the increase of papillary thyroid carcinoma. The reasons behind the increase are complex, multifactorial, and incompletely understood. The most obvious reasons are increased use of diagnostic entities, change in classification of thyroid neoplasms, as well as factors such as obesity, environmental risk factors, and radiation. The prognosis of the patients with papillary thyroid carcinoma is generally good after treatment. Nevertheless, cancer recurrence and comorbidity of second primary cancer may occur, and it is important to have awareness of the clinical, pathological, and molecular parameters of papillary thyroid carcinoma.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Classification; Epidemiology; Incidence; Papillary thyroid carcinoma; Radiation

Mesh:

Substances:

Year:  2022        PMID: 35670964     DOI: 10.1007/978-1-0716-2505-7_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

Review 1.  Thyroid Diseases and Thyroid Asymptomatic Dysfunction in People Living With HIV.

Authors:  Cristina Micali; Ylenia Russotto; Benedetto Maurizio Celesia; Laura Santoro; Andrea Marino; Giovanni Francesco Pellicanò; Giuseppe Nunnari; Emmanuele Venanzi Rullo
Journal:  Infect Dis Rep       Date:  2022-09-01

2.  Analysis of the Mechanism of Maslinic Acid on Papillary Thyroid Carcinoma Based on RNA-Seq Technology.

Authors:  Rong Li; Yanjiao Zhang; Runqing Xiang; Aihe Lin; Zongxiao Xia; Xiaomei Long; Shuang Guo; Yuan Fan; Zukun Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-07       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.